Moberg Pharma AB (publ)

Kvartalsrapporter

Visar 1 grupper

  1. Kvartalsrapport Q1 2026

    ENSV
    →

    Financial Performance

    • Net revenue for the first quarter was SEK 4.9 million (3.9).
    • EBITDA improved to SEK -1.5 million (-3.7).
    • Operating profit (EBIT) was SEK -1.9 million (-4.1).
    • Profit for the period was SEK -1.3 million (-2.8).
    • Cash and cash equivalents amounted to SEK 222.5 million (268.9) at the end of the…

    Öppna rapport